These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 38157850)
1. Gains of 20q11.21 in human pluripotent stem cells: Insights from cancer research. Krivec N; Ghosh MS; Spits C Stem Cell Reports; 2024 Jan; 19(1):11-27. PubMed ID: 38157850 [TBL] [Abstract][Full Text] [Related]
2. Aneuploidy in pluripotent stem cells and implications for cancerous transformation. Na J; Baker D; Zhang J; Andrews PW; Barbaric I Protein Cell; 2014; 5(8):569-79. PubMed ID: 24899134 [TBL] [Abstract][Full Text] [Related]
3. Genetic and epigenetic instability in human pluripotent stem cells. Nguyen HT; Geens M; Spits C Hum Reprod Update; 2013; 19(2):187-205. PubMed ID: 23223511 [TBL] [Abstract][Full Text] [Related]
4. Anti-apoptotic Mutations Desensitize Human Pluripotent Stem Cells to Mitotic Stress and Enable Aneuploid Cell Survival. Zhang J; Hirst AJ; Duan F; Qiu H; Huang R; Ji Y; Bai L; Zhang F; Robinson D; Jones M; Li L; Wang P; Jiang P; Andrews PW; Barbaric I; Na J Stem Cell Reports; 2019 Mar; 12(3):557-571. PubMed ID: 30773485 [TBL] [Abstract][Full Text] [Related]
5. Functional in vivo and in vitro effects of 20q11.21 genetic aberrations on hPSC differentiation. Jo HY; Lee Y; Ahn H; Han HJ; Kwon A; Kim BY; Ha HY; Kim SC; Kim JH; Kim YO; Kim S; Koo SK; Park MH Sci Rep; 2020 Oct; 10(1):18582. PubMed ID: 33122739 [TBL] [Abstract][Full Text] [Related]
6. The safety of human pluripotent stem cells in clinical treatment. Simonson OE; Domogatskaya A; Volchkov P; Rodin S Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342 [TBL] [Abstract][Full Text] [Related]
7. Gain of 20q11.21 in human embryonic stem cells improves cell survival by increased expression of Bcl-xL. Nguyen HT; Geens M; Mertzanidou A; Jacobs K; Heirman C; Breckpot K; Spits C Mol Hum Reprod; 2014 Feb; 20(2):168-77. PubMed ID: 24217388 [TBL] [Abstract][Full Text] [Related]
8. The Impact of Acquired Genetic Abnormalities on the Clinical Translation of Human Pluripotent Stem Cells. Keller A; Spits C Cells; 2021 Nov; 10(11):. PubMed ID: 34831467 [TBL] [Abstract][Full Text] [Related]
9. Female human pluripotent stem cells rapidly lose X chromosome inactivation marks and progress to a skewed methylation pattern during culture. Geens M; Seriola A; Barbé L; Santalo J; Veiga A; Dée K; Van Haute L; Sermon K; Spits C Mol Hum Reprod; 2016 Apr; 22(4):285-98. PubMed ID: 26786180 [TBL] [Abstract][Full Text] [Related]
10. In Vivo Tumorigenicity of the 20q11.21 Amplicon in an Engraftment Model of hPSCs and Differentiated Liver Cells. Pridgeon CS; Forootan SS; Zhang F; Harper N; Palmer D; Weightmann R; Gregory S; Hewitt Z; Baker D; Halliwell J; Moore H; Ricci E; Andrews PW; Poptani H; Hay DC; Park BK; Goldring CEP J Stem Cells Regen Med; 2023; 19(1):3-13. PubMed ID: 37366409 [TBL] [Abstract][Full Text] [Related]
11. Culturing human pluripotent stem cells for regenerative medicine. Ozawa H; Matsumoto T; Nakagawa M Expert Opin Biol Ther; 2023; 23(6):479-489. PubMed ID: 37345510 [TBL] [Abstract][Full Text] [Related]
12. Prediction of Differentiation Tendency Toward Hepatocytes from Gene Expression in Undifferentiated Human Pluripotent Stem Cells. Yanagihara K; Liu Y; Kanie K; Takayama K; Kokunugi M; Hirata M; Fukuda T; Suga M; Nikawa H; Mizuguchi H; Kato R; Furue MK Stem Cells Dev; 2016 Dec; 25(24):1884-1897. PubMed ID: 27733097 [TBL] [Abstract][Full Text] [Related]
13. Assessing Cell Competition in Human Pluripotent Stem Cell (hPSC) Cultures. Price CJ; Barbaric I Curr Protoc; 2022 May; 2(5):e435. PubMed ID: 35621694 [TBL] [Abstract][Full Text] [Related]
14. Gain of 20q11.21 in Human Pluripotent Stem Cells Impairs TGF-β-Dependent Neuroectodermal Commitment. Markouli C; Couvreu De Deckersberg E; Regin M; Nguyen HT; Zambelli F; Keller A; Dziedzicka D; De Kock J; Tilleman L; Van Nieuwerburgh F; Franceschini L; Sermon K; Geens M; Spits C Stem Cell Reports; 2019 Jul; 13(1):163-176. PubMed ID: 31178415 [TBL] [Abstract][Full Text] [Related]
15. Scalable manufacturing of clinical-grade differentiated cardiomyocytes derived from human-induced pluripotent stem cells for regenerative therapy. Morita Y; Kishino Y; Fukuda K; Tohyama S Cell Prolif; 2022 Aug; 55(8):e13248. PubMed ID: 35534945 [TBL] [Abstract][Full Text] [Related]
16. Recurrent Genetic Abnormalities in Human Pluripotent Stem Cells: Definition and Routine Detection in Culture Supernatant by Targeted Droplet Digital PCR. Assou S; Girault N; Plinet M; Bouckenheimer J; Sansac C; Combe M; Mianné J; Bourguignon C; Fieldes M; Ahmed E; Commes T; Boureux A; Lemaître JM; De Vos J Stem Cell Reports; 2020 Jan; 14(1):1-8. PubMed ID: 31902703 [TBL] [Abstract][Full Text] [Related]